These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25336017)

  • 1. R&D productivity rides again?
    Lendrem D; Senn SJ; Lendrem BC; Isaacs JD
    Pharm Stat; 2015; 14(1):1-3. PubMed ID: 25336017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical R&D: the road to positive returns.
    David E; Tramontin T; Zemmel R
    Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471
    [No Abstract]   [Full Text] [Related]  

  • 3. Escaping the pincer.
    Nat Rev Drug Discov; 2009 Dec; 8(12):915. PubMed ID: 19967796
    [No Abstract]   [Full Text] [Related]  

  • 4. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery: are productivity metrics inhibiting motivation and creativity?
    Ullman F; Boutellier R
    Drug Discov Today; 2008 Nov; 13(21-22):997-1001. PubMed ID: 18652910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R&D productivity: on the comeback trail.
    Schulze U; Baedeker M; Chen YT; Greber D
    Nat Rev Drug Discov; 2014 May; 13(5):331-2. PubMed ID: 24751818
    [No Abstract]   [Full Text] [Related]  

  • 7. Research and development productivity map: visualization of industry status.
    Shimura H; Masuda S; Kimura H
    J Clin Pharm Ther; 2014 Apr; 39(2):175-80. PubMed ID: 24438433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The productivity crisis in pharmaceutical R&D.
    Pammolli F; Magazzini L; Riccaboni M
    Nat Rev Drug Discov; 2011 Jun; 10(6):428-38. PubMed ID: 21629293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviving an R&D pipeline: a step change in the Phase II success rate.
    Wu SS; Fernando K; Allerton C; Jansen KU; Vincent MS; Dolsten M
    Drug Discov Today; 2021 Feb; 26(2):308-314. PubMed ID: 33129994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of R&D productivity in the pharmaceutical industry.
    Dimitri N
    Trends Pharmacol Sci; 2011 Dec; 32(12):683-5. PubMed ID: 22030299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to improve R&D productivity: the pharmaceutical industry's grand challenge.
    Paul SM; Mytelka DS; Dunwiddie CT; Persinger CC; Munos BH; Lindborg SR; Schacht AL
    Nat Rev Drug Discov; 2010 Mar; 9(3):203-14. PubMed ID: 20168317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Models for open innovation in the pharmaceutical industry.
    Schuhmacher A; Germann PG; Trill H; Gassmann O
    Drug Discov Today; 2013 Dec; 18(23-24):1133-7. PubMed ID: 23892183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schrödinger's pipeline and the outsourcing of pharmaceutical innovation.
    McMeekin P; Lendrem DW; Lendrem BC; Pratt AG; Peck R; Isaacs JD; Jones D
    Drug Discov Today; 2020 Mar; 25(3):480-484. PubMed ID: 31835019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value networks identify innovation in 21st century pharmaceutical research.
    Edwards PJ
    Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What should be done to improve the productivity of neurological research?
    Moses H; Martin JB
    Ann Neurol; 2006 Dec; 60(6):647-51. PubMed ID: 17192925
    [No Abstract]   [Full Text] [Related]  

  • 16. How to revive breakthrough innovation in the pharmaceutical industry.
    Munos BH; Chin WW
    Sci Transl Med; 2011 Jun; 3(89):89cm16. PubMed ID: 21715677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving R&D productivity.
    Smietana K; Ekstrom L; Jeffery B; Møller M
    Nat Rev Drug Discov; 2015 Jul; 14(7):455-6. PubMed ID: 26065405
    [No Abstract]   [Full Text] [Related]  

  • 18. R&D efficiency of leading pharmaceutical companies - A 20-year analysis.
    Schuhmacher A; Wilisch L; Kuss M; Kandelbauer A; Hinder M; Gassmann O
    Drug Discov Today; 2021 Aug; 26(8):1784-1789. PubMed ID: 34022459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking outward: content as a service starts to make sense.
    Sherlock A
    Drug Discov Today; 2013 Jan; 18(1-2):1-3. PubMed ID: 23041498
    [No Abstract]   [Full Text] [Related]  

  • 20. The case for entrepreneurship in R&D in the pharmaceutical industry.
    Douglas FL; Narayanan VK; Mitchell L; Litan RE
    Nat Rev Drug Discov; 2010 Sep; 9(9):683-9. PubMed ID: 20725093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.